Human acellular dermal wound matrix for treatment of DFU: Literature review and analysis

Journal of Wound Care

Volumn 24, Issue 3, 2015, Pages 128-134

  Reyzelman, A M ^a   Bazarov, I ^a  

^a California School of Podiatric Medicine   (United States)

Author keywords

Acellular dermal matrix; ADM; Diabetic foot ulcer; Human acellular dermal wound matrix; Regenerative tissue matrix

Indexed keywords

ACELLULAR DERMAL MATRIX; COMPARATIVE STUDY; DIABETIC FOOT; EVALUATION STUDY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN TRANSPLANTATION; WOUND HEALING;

ACELLULAR DERMIS; DIABETIC FOOT; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN TRANSPLANTATION; WOUND HEALING;

EID: 84924989599     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2015.24.3.128     Document Type: Review

References (43)

1. Sheehan, P., Jones, P., Caselli, A. et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003;26:6, 1879-1882.
2. Brem, H., Tomic-Canic, M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007;117:5, 1219-1222.
3. Niezgoda, J. A., Van Gils, C. C., Frykberg, R. G., Hodde, J. P. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 2005;18:5 Pt 1, 258-266.
4. Peters, E. J., Lavery, L. A., Armstrong, D. G., Fleischli, J. G. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Arch Phys Med Rehabil 2001;82:6, 721-725.
5. Armstrong, D. G., Lavery, L. A., Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:9498, 1704-1710.
6. Blume, P. A., Walters, J., Payne, W. et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008;31:4, 631-636.
7. Marston, W. A., Hanft, J., Norwood, P. et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003;26:6, 1701-1705.
8. Veves, A., Falanga, V., Armstrong, D. G. et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24:2, 290-295.
9. Reyzelman, A., Crews, R. T., Moore, J. C. et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J 2009;6:3, 196-208.
10. Wu, S. C., Marston, W., Armstrong, D. G. Wound care: the role of advanced wound-healing technologies. J Am Podiatr Med Assoc 2010;100:5, 385-394.
11. Wainwright, D. J. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995;21:4, 243-248.
12. Limova, M. Active wound coverings: bioengineered skin and dermal substitutes. Surg Clin North Am 2010;90:6, 1237-1255.
13. Badylak, S. F. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 2004;12:3-4, 367-377.
14. Chaplin, J. M., Costantino, P. D., Wolpoe, M. E. et al. Use of an acellular dermal allograft for dural replacement: an experimental study. Neurosurgery 1999;45:2, 320-327.
15. Cornwell, K. G., Landsman, A., James, K. S. Extracellular matrix biomaterials for soft tissue repair. Clin Podiatr Med Surg 2009;26:4, 507-523.
16. Harding, K., Kirsner, R., Lee, D. et al. International Consensus: Acellular matrices for the treatment of wounds. Wounds International 2010;1-13.
17. Brigido, S. A. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 2006;3:3, 181-187.
18. Brigido, S. A., Boc, S. F., Lopez, R. C. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. Orthopedics 2004;27:1 Suppl, s145-s149.
19. Martin, B. R., Sangalang, M., Wu, S., Armstrong, D. G. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience. Int Wound J 2005;2:2, 161-165.
20. Higgins, J. P., Green, S. The Cochrane Collaboration's tool for assessing risk of bias. In: Higgins, J. P., Green, S. (eds). Cochrane Handbook for Systematic Reviews of Interventions Part 2: General Methods for Cochrane Reviews. The Cochrane Collaboration, 2011.
21. Higgins, J. P., Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:11, 1539-1558.
22. Stacey, D. H. Use of an acellular regenerative tissue matrix over chronic wounds. Eplasty 2013;13:e61.
23. Nusbaum, A. G., Martell, E. G., Bard, S. et al. Excision and grafting of palmoplantar keratoderma. J Craniofac Surg 2009;20:6, 2241-2243.
24. Neill, J., James, K., Lineaweaver, W. Utilizing biologic assimilation of bovine fetal collagen in staged skin grafting. Ann Plast Surg 2012;68:5, 451-456.
25. Branch, J. P. A tendon graft weave using an acellular dermal matrix for repair of the achilles tendon and other foot and ankle tendons. 1 J Foot Ankle Surg 2011;50:2, 257-265.
26. Papanas, N., Eleftheriadou, I., Tentolouris, N., Maltezos, E. Advances in the topical treatment of diabetic foot ulcers. Curr Diabetes Rev 2012;8:3, 209-218.
27. Song, J. J., Ott, H. C. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 2011;17:8, 424-432.
28. Barber, F. A., McGarry, J. E., Herbert, M. A., Anderson, R. B. A biomechanical study of Achilles tendon repair augmentation using GraftJacket matrix. Foot Ankle Int 2008;29:3, 329-333.
29. Chen, B., Jia, C. Y., Hu, D. H. et al. [Functional reconstruction of multiple severe deformities after extensive deep burn]. Zhonghua Shao Shang Za Zhi 2008;24:5, 355-358.
30. Chen, X. L., Xia, Z. F., Fang, L. S. et al. Co-graft of acellular dermal matrix and autogenous microskin in a child with extensive burns. Ann Burns Fire Disasters 2008;21:2, 102-106.
31. Knox, K., Bitzos, I., Granick, M. et al. Immediate reconstruction of oncologic hemipelvectomy defects. Ann Plast Surg 2006;57:2, 184-189.
32. Lee, D. K. Achilles tendon repair with acellular tissue graft augmentation in neglected ruptures. J Foot Ankle Surg 2007;46:6, 451-455.
33. Lee, D. K. A preliminary study on the effects of acellular tissue graft augmentation in acute Achilles tendon ruptures. J Foot Ankle Surg 2008;47:1, 8-12.
34. Liden, B. A., Simmons, M. Histologic evaluation of a 6-month GraftJacket matrix biopsy used for Achilles tendon augmentation. J Am Podiatr Med Assoc 2009;99:2, 104-107.
35. Rapley, J. H., Crates, J., Barber, A. Mid-substance peroneal tendon defects augmented with an acellular dermal matrix allograft. Foot Ankle Int 2010;31:2, 136-140.
36. Brigido, S. A., Schwartz, E., McCarroll, R., Hardin-Young, J. Use of an acellular flowable dermal replacement scaffold on lower extremity sinus tract wounds: a retrospective series. Foot Ankle Spec 2009;2:2, 67-72.
37. Kimmel, H., Rahn, M., Gilbert, T. W. The clinical effectiveness in wound healing with extracellular matrix derived from porcine urinary bladder matrix: a case series on severe chronic wounds. J Am Coll Cert Wound Spec 2010;2:3, 55-59.
38. Wagner, F. W. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2:2, 64-122.
39. Lavery, L. A., Armstrong, D. G., Harkless, L. B. Classification of diabetic foot wounds. Ostomy Wound Manage 1997;43:2, 44-53.
40. Mostow, E. N., Haraway, G. D., Dalsing, M. et al. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 2005;41:5, 837-843.
41. Romanelli, M., Dini, V., Bertone, M. et al. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 2007;4:1, 3-7.
42. Driver, V. R., Fabbi, M., Lavery, L. A., Gibbons, G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 2010;52:3 Suppl, 17S-22S.
43. Winters, C. L., Brigido, S. A., Liden, B. A. et al. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Adv Skin Wound Care 2008;21:8, 375-381.